Healthcare -
Drug Manufacturers - General - NYSE - US
$ 14.695
1.27 %
$ 3.79 B
Market Cap
4.41
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Organon & Co.
| Net Income | 864 M |
| Depreciation & Amortization | 132 M |
| Capital Expenditures | -175 M |
| Stock-Based Compensation | 105 M |
| Change in Working Capital | 0 |
| Others | -2 M |
| Free Cash Flow | 764 M |
Cash Flow
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||
| Net Income | 864.0 | 1 023.0 | 917.0 | 1 351.0 | 2 160.0 | 3 306.0 | 2 153.0 | 1 801.0 |
| Depreciation & Amortization | 132.0 | 236.0 | 212.0 | 195.0 | 157.0 | 333.0 | 1 673.0 | 1 973.0 |
| Deferred Income Tax | (160.0) | (485.0) | (18.0) | (288.0) | 6.0 | 12.0 | 37.0 | (1 045.0) |
| Stock Based Compensation | 105.0 | 101.0 | 75.0 | 59.0 | 40.0 | 41.0 | 56.0 | 56.0 |
| Other Operating Activities | (2.0) | 79.0 | 124.0 | 439.0 | 7.0 | (253.0) | (58.0) | 5 480.0 |
| Change in Working Capital | 0 | (155.0) | (452.0) | 702.0 | (197.0) | (672.0) | (174.0) | (1 435.0) |
| Cash From Operations | 939.0 | 799.0 | 858.0 | 2 458.0 | 2 187.0 | 2 767.0 | 3 687.0 | 3 419.0 |
| INVESTING CASH FLOW | ||||||||
| Capital Expenditures | (175.0) | (261.0) | (427.0) | (488.0) | (278.0) | (92.0) | (101.0) | (86.0) |
| Other Items | (338.0) | 1.0 | 7.0 | 7.0 | 20.0 | (10.0) | 32.0 | 30.0 |
| Cash From Investing Activities | (513.0) | (260.0) | (420.0) | (481.0) | (258.0) | (102.0) | (69.0) | (56.0) |
| FINANCING CASH FLOW | ||||||||
| Common Stock Repurchased | 0 | (17.0) | (11.0) | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (11.0) | (258.0) | (108.0) | 7 846.0 | 1 512.0 | 0 | 59.0 | (4.0) |
| Dividends Paid | (297.0) | (294.0) | (290.0) | (145.0) | 0 | 0 | 0 | 0 |
| Other Financing Activities | (60.0) | (17.0) | (35.0) | (9 034.0) | (3 687.0) | (2 621.0) | (4 223.0) | (3 368.0) |
| Cash From Financing Activities | (368.0) | (569.0) | (433.0) | (1 333.0) | (2 175.0) | (2 621.0) | (4 164.0) | (3 372.0) |
| CHANGE IN CASH | ||||||||
| Net Change In Cash | (18.0) | (13.0) | (31.0) | 667.0 | (249.0) | 75.0 | (527.0) | (45.0) |
| FREE CASH FLOW | ||||||||
| Free Cash Flow | 764.0 | 538.0 | 431.0 | 1 970.0 | 1 909.0 | 2 675.0 | 3 586.0 | 3 333.0 |